About PEIJIA-B Company

The company is a global provider of innovative medical products and solutions. We focus on the high-growth interventional medical device market in China. Our products and products under development target large-scale, rapidly growing markets with insufficient penetration and high entry barriers, including the transcatheter valve therapy medical device market and the interventional neurological surgery medical device market. Our vision Become a patient-centered, original and respected global high-tech medical enterprise. Our mission We are committed to providing safe, effective, and patient-accessible products and solutions through continuous innovation to reduce patient pain and improve patients' quality of life. Our product pipeline As of the date of this annual report, our product pipeline includes transcatheter valve treatment and neurological intervention products and products under development, covering three key business segments: transcatheter valve treatment business, cutting-edge technology business, and neurological intervention business. In the transcatheter valve treatment business, we have three commercialized TAVR systems — TaurusOne, TaurusElite, and TaurusMax, four commercialized surgical accessories, and multiple products under development for transcatheter aortic valve replacement, transcatheter mitral valve, and transcatheter tricuspid valve replacement and repair at different stages of development. In the cutting-edge technology business, we have three products under development. In the neurological intervention business, we have 17 commercialized products and various products under development at different stages of development, covering hemorrhagic and ischemic strokes and vascular pathways.